WE3-29736-51863 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-29
Dose 1 — Pfizer-BioNTech
2021-04-20
Registered in v-safe
2021-04-20
Dose 2 — Pfizer-BioNTech
2021-04-20
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-26
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-27
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-04
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-11
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-18
Survey response — day 28, dose 2
MedDRA: Headache, Myalgia — Feeling: Fair · Be unable to work

Free text: Headaches and muscle soreness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-25
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-01
Survey response — day 42, dose 2
MedDRA: Adverse reaction, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities

Free text: Shortness of w

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-20
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-19
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-28
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-04-20
Survey response — 12 months, dose 2
MedDRA: Cough, Fatigue, Wheezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Cough, wheezing, fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-04-20
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-04-21
Call 1 — Left Voicemail
2022-04-28
Health check-in — 6 months, dose 3
Feeling: Poor

Adult check-in
2022-10-28
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-29	Pfizer-BioNTech
2	2021-04-20	Pfizer-BioNTech
3	2021-10-28	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-04-20	Unsuccessful

Free text

Release 8 — day 28, dose 2

2021-05-18

Symptoms: Headaches and muscle soreness

Release 8 — day 42, dose 2

2021-06-01

Symptoms: Shortness of w

Release 11 — 12 months, dose 2

2022-04-20

Symptoms: Cough, wheezing, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adverse reaction	✓	·	✓
SD	Cough	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	✓	✓	✓
SD	Myalgia	✓	✓	✓
SD	Unevaluable event	○	✓	○
SD	Wheezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release